Krishna Prasad Tumuluri
Direktor/Vorstandsmitglied bei Aurore Life Science Pvt Ltd.
Profil
Krishna Prasad Tumuluri is currently working as an Investment Director at iLabs Group.
He is also a Director at Skanda Aerospace Pvt Ltd., Sigma Microsystems Pvt Ltd., and Aurore Life Science Pvt Ltd.
He completed his undergraduate degree from the University of Madras.
Aktive Positionen von Krishna Prasad Tumuluri
Unternehmen | Position | Beginn |
---|---|---|
Aurore Life Science Pvt Ltd.
Aurore Life Science Pvt Ltd. Pharmaceuticals: GenericHealth Technology Aurore Life Science Pvt Ltd is a pure-play active pharmaceutical ingredient (API) private company that was founded in 2017. The company is based in Hyderabad, India and has manufacturing facilities with a combined capacity of 600 kl, including a flagship facility approved by USFDA, EDQM, WHO, and other regulatory agencies. Aurore is rapidly emerging as the most preferred API and key API intermediates supply partner for leading pharmaceutical companies. The Indian company's strategy is to be a fully integrated API company with complete control of key starting materials, advanced intermediates, and high-quality final products. Aurore has a strong team of R&D experts that complement their strategy, and they are rapidly establishing themselves as a reliable partner to serve unmet demands of the market. The CEO is Rajender Juvvadi Rao. | Direktor/Vorstandsmitglied | - |
Skanda Aerospace Pvt Ltd.
Skanda Aerospace Pvt Ltd. Computer CommunicationsElectronic Technology Skanda Aerospace Pvt Ltd. manufactures and distributes radio frequency and microwave systems. The company is headquartered in Hyderabad, India. | Direktor/Vorstandsmitglied | 11.09.2017 |
Sigma Microsystems Pvt Ltd.
Sigma Microsystems Pvt Ltd. Aerospace & DefenseElectronic Technology Sigma Microsystems Pvt Ltd. manufactures and distributes navigation and targeting equipment. Its services include system solution and engineering software and hardware design and development. The firm’s products include PMC/XMC and USB I/O modules, railways data logger and embedded systems. The company was founded in 1994 and is headquartered in Hyderabad, India. | Direktor/Vorstandsmitglied | 21.09.2016 |
iLabs Group
iLabs Group Investment ManagersFinance iLabs Group (iLabs) is a private equity/venture capital firm founded in 2000 by Srinivasa Raju Chintalapati. The firm is headquartered in India. | Private Equity Investor | - |
Ausbildung von Krishna Prasad Tumuluri
University of Madras | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
iLabs Group
iLabs Group Investment ManagersFinance iLabs Group (iLabs) is a private equity/venture capital firm founded in 2000 by Srinivasa Raju Chintalapati. The firm is headquartered in India. | Finance |
Skanda Aerospace Pvt Ltd.
Skanda Aerospace Pvt Ltd. Computer CommunicationsElectronic Technology Skanda Aerospace Pvt Ltd. manufactures and distributes radio frequency and microwave systems. The company is headquartered in Hyderabad, India. | Electronic Technology |
Sigma Microsystems Pvt Ltd.
Sigma Microsystems Pvt Ltd. Aerospace & DefenseElectronic Technology Sigma Microsystems Pvt Ltd. manufactures and distributes navigation and targeting equipment. Its services include system solution and engineering software and hardware design and development. The firm’s products include PMC/XMC and USB I/O modules, railways data logger and embedded systems. The company was founded in 1994 and is headquartered in Hyderabad, India. | Electronic Technology |
Aurore Life Science Pvt Ltd.
Aurore Life Science Pvt Ltd. Pharmaceuticals: GenericHealth Technology Aurore Life Science Pvt Ltd is a pure-play active pharmaceutical ingredient (API) private company that was founded in 2017. The company is based in Hyderabad, India and has manufacturing facilities with a combined capacity of 600 kl, including a flagship facility approved by USFDA, EDQM, WHO, and other regulatory agencies. Aurore is rapidly emerging as the most preferred API and key API intermediates supply partner for leading pharmaceutical companies. The Indian company's strategy is to be a fully integrated API company with complete control of key starting materials, advanced intermediates, and high-quality final products. Aurore has a strong team of R&D experts that complement their strategy, and they are rapidly establishing themselves as a reliable partner to serve unmet demands of the market. The CEO is Rajender Juvvadi Rao. | Health Technology |